Pretreatment blood pressure as a predictor of 21-year mortality

American Journal of Hypertension

Volumn 13, Issue 6 II SUPPL., 2000, Pages 724-733

  Perry Jr , H Mitchell ^a,c   Miller, J Philip ^a   Baty, Jack D ^a   Carmody, Sharon E ^a   Sambhi, Mohinder P ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Body mass index; Diastolic blood pressure; Hypertension; Pulse pressure; Race; Systolic blood pressure

Indexed keywords

ADULT; AGE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NEGRO; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RACE DIFFERENCE; REVIEW; RISK; SOLDIER; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAUSE OF DEATH; HOSPITALS, VETERANS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0033928230     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00214-9     Document Type: Review

References (24)

1. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
2. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
3. Build and Blood Pressure Study 1959. Society of Actuaries, Chicago, 1959.
4. Blood Pressure Study 1979. Society of Actuaries and Association of Life Insurance Medical Directors of America. Boston, 1980.
5. Perry HM Jr, Schnaper HW, Meyer G, Swatzell R: Clinical program for screening and treatment of hypertension in veterans. J Nat Med Assoc 1982;74:433-444.
6. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Int Med 1997;157:2413-2446.
7. Miller JP, Perry HM Jr, Rossiter JE, Baty JD, Carmody SE, Sambhi MP: Regional differences in mortality during 15-year follow-up of 11,936 hypertensive veterans. Hypertension 1994;23:431-438.
8. Perry HM, Belton ED, Moses C, Moss WG, Page IR, Smith WM, Sokolow M, Witwer BD: National High Blood Pressure Education Program Report to the Hypertension Information and Education Advisory Committee, Task Force I Data Base. 1973; US Dept of Health, Education, and Welfare Publication No. (NIH) 74-593.
9. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
10. Kirkendall WM, Burton AC, Epstein FH, Freis ED: Recommendations for human blood pressure determination by sphygmomanometer. Circulation 1967;36:980-988.
11. Boyle CA, Decoufle P: National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990;131:160-168.
12. Grambsch PM, Therneau TM, Fleming TR: Diagnostic plots to reveal functional forms for covariates in multiplicative intensity models. Biometrics 1995;51:1469-1482.
13. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH: Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995;345:825-829.
14. Therneau TM, Grambsch PA, Fleming TR: Martingale-based residuals for survival models. Biometrika 1990; 77:147-160.
15. Stamler J, Neaton JD, Wentworth DN: Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13(suppl I):I-2-I-12.
16. Flack JM, Neaton J, Grimm R Jr, Shih J, Cutler J, Ensrud K, MacMahon S, for the Multiple Risk Factor Intervention Trial Research Group: Blood pressure and mortality among men with prior myocardial infarction. Circulation 1995;92:2437-2445.
17. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA: Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med 1993;329:73-78.
18. Rabkin SW, Mathewson FA, Tate RB: Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Int Med 1978;88:342-345.
19. Kannel WB, Gordon T, Schwartz MJ: Systolic versus diastolic blood pressure and the risk of coronary heart disease. The Framingham Study. Am J Cardiol 1971;27: 335-346.
20. Schick FL, Schick E: Statistical handbook on aging Americans, 1994 edition. Oryx Press, Phoenix, 1994, pp 133, 134.
21. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their causes and prognosis. Am J Med Sci 1939;197:332-343.
22. Smith DE, Odell HMO, Kernohan JW: Causes of death in hypertension. Am J Med 1950;9:516-527.
23. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examinations surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
24. Stamler R, Ford CE, Stamler J: Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension 1991;17:553-564.